by MASA | Jul 31, 2024 | Drug Updates
The FDA approved Zoryve cream (0.15%) for mild to moderate atopic dermatitis this year for adults and children aged above 6 years old. Roflumilast cream (marketed under the name Zoryve) is a non-steroidal topical cream that is applied once daily to affected areas of...
by MASA | May 13, 2024 | Immunodeficiency Hypogammaglobulinemia, Uncategorized
As allergists, your providers not only deal with over-reactions of your immune system but also immunodeficiency. Listen to the 3-minute clip to learn the brief introduction to immunodeficiency by Dr. Dareen Siri to understand if you or your loved ones may have...
by MASA | Apr 23, 2024 | Drug Updates, News
The U.S. Food and Drug Administration (FDA) has provided an emergency use authorization (EUA) for a new medicine called Pemgarda™ (pemivibart), aimed at preventing COVID-19 in certain high-risk individuals. This medication is specifically designed for those who are...
by MASA | Mar 31, 2024 | Drug Updates
US FDA approved of XHANCE as the first and only medication for adults with chronic rhinosinusitis without nasal polyps. It is a fluticasone propionate nasal spray which uses the Exhalation Delivery System to enable topical steroid to the inflamed areas and is proven...
by MASA | Mar 11, 2024 | Allergies, Anaphylaxis, Asthma
Central Illinois School Asthma and Allergy Resources for Students Welcome to the Central Illinois School Health Resources page! This page aims to unify and provide essential information and resources for schools and school nurses to promote student health and safety...
